ProCE Banner Events

A Treatment Option for Patients with ER+/HER2-ESR1-mutated mBC Following Progression on Initial ET +/- a CDK4/6i

Join us to gain insights on metastatic breast cancer second line options.

Key Takeaways:

  • Understanding testing and treatment for ESR1-mutated mBC

This event has expired. No longer available for credits.

Time and location

Friday, December 20, 2024

11:00 AM - 11:30 AM Eastern Time (ET)

Virtual

Acknowledgement

Sponsored By

Stemline

Stemline